1. |
Rahimy E, Sarraf D. Paraneoplastic and non-paraneoplastic retinopathy and optic neuropathy: evaluation and management [J]. Surv Ophthalmol, 2013, 58(5): 430-458. DOI: 10.1016/ j.survophthal.2012.09.001.
|
2. |
杨丽珠, 睢瑞芳. 副肿瘤性视网膜病变的发病机制及临床特点[J]. 中华实验眼科杂志, 2016, 34(5): 476-480. DOI: 10.3760/cma.j.issn.2095-0160.2016.05.018.Yang LZ,Sui RF. The mechanism and clinical features of paraneoplastic retinopathy[J]. Chin J Exp Ophthalmol, 2016, 34(5): 476-480. DOI: 10.3760/cma.j.issn.2095-0160.2016.05.018.
|
3. |
Ikawa M, Kuriyama M.Paraneoplastic retinopathy and optic neuropathy[J]. Brain Nerve, 2010, 62(4): 371-376.
|
4. |
Adamus G. Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy [J]. Autoimmun Rev, 2009, 8(5): 410-414. DOI: 10.1016/j.autrev.2009.01.002.
|
5. |
Chan JW. Paraneoplastic retinopathies and optic neuropathies [J]. Surv Ophthalmol, 2003, 48(1): 12-38.
|
6. |
Anastasakis A, Dick AD, Damato EM, et al. Cancer-associated retinopathy presenting as retinal vasculitis with a negative ERG suggestive of on-bipolar cell pathway dysfunction [J]. Doc Ophthalmol, 2011, 123(1): 59-63. DOI: 10.1007/s10633-011-9277-y.
|
7. |
Matsui Y, Mehta MC, Katsumi O, et al. Electrophysiological findings in paraneoplastic retinopathy [J].Graefe's Arch Clin Exp Ophthalmol, 1992, 230(4): 324-328.
|
8. |
Lima LH, Greenberg JP, Greenstein VC, et al. Hyperautofluorescent ring in autoimmune retinopathy [J]. Retina, 2012, 32(7): 1385-1394. DOI: 10.1097/IAE.0b013e3182398107.
|
9. |
黄厚斌, 魏世辉, 李莹, 等. 副肿瘤性视网膜视神经病变临床特征初步分析[J]. 中华眼科杂志, 2013, 49(6): 507-513. DOI: 10.3760/cma.j.issn.0412-4081.2013.06.008.Huang HB, Wei SH, Li Y, et al. Clinical characteristics of paraneoplastic retinopathy and optic neuropathy[J]. Chin J Ophthalmol, 2013, 49(6): 507-513. DOI: 10.3760/cma.j.issn.0412-4081.2013.06.008.
|
10. |
Sakamori Y, Kim YH, Okuda C, et al. Two cases of cancer-associated retinopathy combined with small-cell lung cancer[J]. Jpn J Clin Oncol ,2011, 41(5):669-673. DOI: 10.1093/jjco/hyr025.
|